‘Charting a new course for prostate cancer’ – currying favor for docetaxel in hormone-sensitive metastatic prostate cancer

  • Mark Voskoboynik, John Staffurth, Zafar Malik, Christopher Sweeney, Simon Chowdhury
  • Expert Review of Anticancer Therapy, October 2014, Taylor & Francis
  • DOI: 10.1586/14737140.2014.971112

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.1586/14737140.2014.971112